| Literature DB >> 35888629 |
Hadel Shahood1, Annamaria Pakai2, Rudolf Kiss3, Bory Eva3, Noemi Szilagyi3, Adrienn Sandor3, Zsofia Verzar4.
Abstract
Background andEntities:
Keywords: elective cardiac surgery; postoperative pulmonary complications; preoperative chest physiotherapy; pulmonary functions
Mesh:
Year: 2022 PMID: 35888629 PMCID: PMC9319848 DOI: 10.3390/medicina58070911
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Figure 1PRISMA study selection flow chart.
The location and design of the included studies.
| Study | Study Place | Study Design | Objected Patients |
|---|---|---|---|
| Hulzebos et al., 2006a | Netherlands | RCT | Patients planned for elective CABG |
| Hulzebos et al., 2006b | Netherlands | RC pilot study | Patients planned for elective CABG, with high risk to develop PPCs. |
| Savci et al., 2011 | Turkey | RCT | Patients planned for elective CABG. |
| Tung et al., 2012 | Taiwan | RC pilot study | Patients planned for CABG and/or valve surgeries. |
| Vakenet et al., 2013 | Netherlands | Observational cohort study | Patients planned for elective CABG, with high risk to develop PPCs. |
| Sobrinho et al., 2014 | Brazil | RCT | Patients planned for elective CABG. |
| Shakuri et al., 2015 | Iran | RCT | Patients planned for open cardiac surgery. |
| Fayyaz et al., 2016 | Pakistan | RCT | Patients planned for elective CABG. |
| Vakenet et al., 2017 | Netherlands | 2ry analyses of RCT | Patients planned for elective CABG. |
| Chen et al., 2019 | China | RC pilot study | Patients planned for CABG and/or valve surgeries. |
RCT: randomized controlled trial; CABG: coronary artery bypass graft; PPCs: postoperative pulmonary complications.
A summary of the sociodemographic data included in the studies.
| Study | N (Total: I–C) | Mean Age (I–C) | Male % (I–C) |
|---|---|---|---|
| Hulzebos et al., 2006a | 276: 139–137 | 66.5–67.3 | 77.7–78.1 |
| Hulzebos et al., 2006b | 26: 14–12 | 70.14–70.5 | 50–50 |
| Savci et al., 2011 | 43: 22–21 | 62.82–57.48 | 86.4–90.5 |
| Tung et al., 2012 | 35: 15–20 | 52.5–54.7 | 93.3–70 |
| Vakenet et al., 2013 | 346: 94–252 | 66.8–68.4 | 61.7–68.3 |
| Sobrinho et al., 2014 | 70: 35–35 | 58.9–61.4 | 65.7–82.9 |
| Shakuri et al., 2015 | 60: 30–30 | 54.4–59.3 | 63.3–66.1 |
| Fayyaz et al., 2016 | 170: 85–85 | 39.44–39.33 | -- |
| Vakenet et al., 2017 | 235: 119–116 | 66–67.5 | 78.2–80.2 |
| Chen et al., 2019 | 197: 98–99 | 61.86–61.86 | 74.5–68.7 |
| Total | 1458: 651–807 | 60.36 | 69.9 |
I: Intervention group; C: Control group.
The risk factors and comorbidities of patients included in the studies.
| Study | Smoking % | BMI Mean | Comorbidity |
|---|---|---|---|
| Hulzebos et al., 2006a | 32.4–38 | 28.3–28.1 | HTN: 57–54.5 |
| Hulzebos et al., 2006b | 29–25 | 26.13–28.32 | DM: 14–25 |
| Savci et al., 2011 | 70.95–71.62 | 27.49–25.73 | HTN, DM, hyperlipidemia, alcohol consumption, inactivity, and family history |
| Tung et al., 2012 | 60–70 | 27.8–26.3 | <3: 86.7–80 |
| Vakenet et al., 2013 | -- | ≥30 (%): 27.7–27.8 | DM: 34–57.1 |
| Sobrinho et al., 2014 | 67–67 | 27.08–26 | -- |
| Shakuri et al., 2015 | 30–33.3 | 26.8–27.7 | DM: 36.7–26.6 |
| Fayyaz et al., 2016 | -- | 28.36–26.20 | -- |
| Vakenet et al., 2017 | 34.5–36.2 | 28.6–28.1 | HTN: 58.8–44 |
| Chen et al., 2019 | 44.9–37.4 | 26.07–25.66 | DM: 25.5–27.3 |
I: intervention group; C: control group; HTN: hypertension; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease.
The type and description of interventions in the included studies.
| Study | Preoperative Intervention | Time Frame/Frequency | Session Duration | Used Tool |
|---|---|---|---|---|
| Hulzebos et al., 2006a | IMT; incentive spirometry, once a week with supervision by a physical therapist. | 2–10 weeks/daily | 20 min | Threshold IMT® |
| Hulzebos et al., 2006b | IMT; incentive spirometry, once a week with supervision by a physical therapist. | 2–4 weeks/daily | 20 min | Threshold IMT® |
| Savci et al., 2011 | IMT under the supervision of a physical therapist. | 5 days/daily | 30 min | Threshold IMT (Respironics, Pittsburg, PA, USA). |
| Tung et al., 2012 | Individualized, tailored exercises—PIEP. The PIEP was set at a low intensity, i.e., achieving 50–60% maximal oxygen consumption (VO2max) for this population, by an expert panel. | 2 weeks/once or twice a weak (3 times) | 40–60 min | Cycle ergometer, spirometer, SF-36 |
| Vakenet et al., 2013 | Unsupervised IMT program at home. | 2 weeks/daily | 20 min/day | Threshold IMT, (Respironics, New Jersey, PA, USA). |
| Sobrinho et al., 2014 | Breathing exercises. | Daily till surgery, once a day | Not specified | Threshold—IMT® |
| Shakuri et al., 2015 | Exercises and auxiliary activities for extension and rotation of thoracic vertebrae, breathing exercises, exercises to expand lung lobes, aerobic exercises at a constant low speed for all the patients. | 25 min | flow-incentive spirometer-based (Respiflow™ FS) | |
| Fayyaz et al., 2016 | Incentive spirometry. | -- | -- | -- |
| Vakenet et al., 2017 | IMT; incentive spirometry; education. | 2 weeks/daily | ||
| Chen et al., 2019 | IMT. | 5 days/twice a day | 20 min | Threshold IMT device (HS730-010; Philips Respironics, Pittsburgh, PA, USA). |
IMT: inspiratory muscle training; PIEP: preoperative individualized exercise prescription.
Description of the preoperative protocols.
| Study | Preoperative Control Group Management | Postoperative Both Groups Management |
|---|---|---|
| Hulzebos et al., 2006a | Care as usual the day before surgery (i.e., instruction on deep breathing maneuvers, coughing, and early mobilization). | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Hulzebos et al., 2006b | Care as usual the day before surgery (i.e., instruction on deep breathing maneuvers, coughing, and early mobilization). | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Savci et al., 2011 | Mobilization, active exercises of upper and lower limbs, chest physiotherapy. | Chest physical therapy and mobilization scheme after operation. |
| Tung et al., 2012 | Care as usual the day before surgery (i.e., instruction on deep breathing maneuvers, coughing, and early mobilization). | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Vakenet et al., 2013 | Received usual care (no IMT). | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Sobrinho et al., 2014 | Only routine ward guidelines before surgery. | Physical therapy as needed by staff physiotherapy service. |
| Shakuri et al., 2015 | -- | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Fayyaz et al., 2016 | -- | -- |
| Vakenet et al., 2017 | Care as usual the day before surgery (i.e., instruction on deep breathing maneuvers, coughing, and early mobilization). | Incentive spirometry, chest physical therapy, and mobilization scheme after operation. |
| Chen et al., 2019 | Both groups received both usual care (i.e., education, coughing and early mobilization) and abdominal breathing training before the surgery. | Chest physical therapy and mobilization scheme after operation. |
IMT: inspiratory muscle training.
The outcomes of the included studies.
| Study | Outcome Measure |
|---|---|
| Hulzebos et al., 2006a | The primary outcome: the incidence of PPCs. |
| Hulzebos et al., 2006 b | Primary outcome variables: the occurrence of adverse events and patient satisfaction and motivation. |
| Savci et al., 2011 | Inspiratory muscle strength (cmH2O). |
| Tung et al., 2012 | Pulmonary complication-related parameters. |
| Vakenet et al., 2013 | The primary outcome measure: postoperative pneumonia. |
| Sobrinho et al., 2014 | The respiratory muscle strength, pulmonary volumes, and |
| Shakuri et al., 2015 | Spirometry parameters; |
| Fayyaz et al., 2016 | Postoperative oxygenation. |
| Vakenet et al., 2017 | Quality of life assessment using Short Form 36-Health Survey (SF-36). |
| Chen et al., 2019 | The primary outcome variable: the occurrence of postoperative pulmonary complications. |
PPCs: postoperative pulmonary complications; ABG: arterial blood gases.
Figure 2Forest plot evaluating surgery time in the included studies.
Figure 3Forest plot evaluating ICU duration stay in the included studies.
Figure 4Forest plot evaluating mechanical ventilation duration in the included studies.
Figure 5Forest plot evaluating hospital stay length in the included studies.
Figure 6Forest plot evaluating FEV1% predicted in the included studies.
Figure 7Forest plot evaluating FVC% predicted in the included studies.
Figure 8Forest plot evaluating Pi-max in the included studies.
Figure 9Forest plot evaluating PPCs in the included studies.
Figure 10Funnel plot for the PPCs incidences reported by the studies.
The outcomes summary of the included studies.
| Study | Outcome Measure |
|---|---|
| Hulzebos et al., 2006a | The primary outcome: a statistically significant difference was found between the two groups in the incidence of PPCs ( |
| Hulzebos et al., 2006b | Primary outcome: the feasibility of the intervention was good. No adverse events were reported. A statistically significant difference was found between the two groups in the satisfaction scores and the muscle strength. |
| Savci et al., 2011 | Statistically significant difference was found between the two groups in the MIT, the improvement in QoL, and the anxiety score of HADS. |
| Tung et al., 2012 | Significant reduction in the non-invasive ventilator ( |
| Vakenet et al., 2013 | Statistically significant difference was found between the two groups in the incidence of PPCs, but not in the LOS |
| Sobrinho et al., 2014 | Statistically significant difference was found between the two groups in the MIT and LOS. |
| Shakuri et al., 2015 | Significant changes in predicted FVC, PEF, and PCO2 concentration in the interventional group compared to the control group. |
| Fayyaz et al., 2016 | Significant postoperative improvement of PO2 and PCO2 in the interventional group compared to the control group. |
| Vakenet et al., 2017 | No significant differences in change of QoL scores over time were found between the intervention and control groups. |
| Chen et al., 2019 | Statistically significant difference was found between the two groups in the incidence of PPCs, the MIT, and LOS. |
PPCs: postoperative pulmonary complications; LOS: length of stay; QoL: quality of life; HADS: Hospital Anxiety and Depression Scale.
Figure 11Risk of bias graph for the included studies.
Figure 12Risk of bias summary for the included studies. A square with a green circle means low risk, a square with a red circle means high risk, and an empty square indicates unclear risk.